Literature & Media

​New Drug Monograph: CHO-4'Me-5'Br-FUBOXPYRA

Monographs


In July 2021, China banned several common synthetic cannabinoid core scaffolds to control the manufacturing and trafficking of these substances. This NPS Discovery Monograph documents the first report of CHO-4'Me-5'Br-FUBOXPYRA, a novel synthetic cannabinoid possessing an alternative 2-oxopyridine core scaffold. Cayman and the CFSRE established the “OXPYRA” systematic naming convention to be structurally informative and parallel existing synthetic cannabinoid NPS nomenclature, such as the OXIZID and IATA class.

Download Copy (PDF)
​New Drug Monograph: CHO-4'Me-5'Br-FUBOXPYRA
Cayman ChemicalCayman ChemicalCayman Chemical

Receive Our News & Literature Directly to Your Inbox!

Log in or register to subscribe to our email list. You will receive emails packed with new products and content that match your research interests. We only email once a week and you can unsubscribe at any time.